|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2005-9-9
|
|
pubmed:abstractText |
Fabry disease is an inherited lysosomal storage disease caused by deficiency of alpha-galactosidase A. Enzyme replacement therapy for this multisystem progressive disease has been available only since 2001. We here report the first known successful pregnancy of a female patient receiving such therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0141-8955
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
787-8
|
|
pubmed:dateRevised |
2007-3-21
|
|
pubmed:meshHeading |
pubmed-meshheading:16151910-Adult,
pubmed-meshheading:16151910-Enzymes,
pubmed-meshheading:16151910-Fabry Disease,
pubmed-meshheading:16151910-Female,
pubmed-meshheading:16151910-Humans,
pubmed-meshheading:16151910-Infant, Newborn,
pubmed-meshheading:16151910-Isoenzymes,
pubmed-meshheading:16151910-Lysosomal Storage Diseases,
pubmed-meshheading:16151910-Male,
pubmed-meshheading:16151910-Pregnancy,
pubmed-meshheading:16151910-Pregnancy Complications,
pubmed-meshheading:16151910-Pregnancy Outcome,
pubmed-meshheading:16151910-Treatment Outcome,
pubmed-meshheading:16151910-alpha-Galactosidase
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa.
|
|
pubmed:affiliation |
Children's University Hospital Mainz, Mainz, Germany.
|
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|
